Austin Health

Title
What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis.
Publication Date
2023-05-02
Author(s)
Venetis, C A
Storr, A
Chua, S J
Mol, B W
Longobardi, S
Yin, X
D'Hooghe, T
Subject
ART
GnRH antagonist
assisted reproductive technologies
cetrorelix
controlled ovarian stimulation
ganirelix
live birth
pregnancy
Type of document
Journal Article
OrcId
0000-0001-9591-7222
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-3934-2302
0000-0001-8337-550X
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-2373-8257
DOI
10.1093/humupd/dmac040
Abstract
Several GnRH antagonist protocols are currently used during COS in the context of ART treatments; however, questions remain regarding whether these protocols are comparable in terms of efficacy and safety.
Link
Citation
Human Reproduction Update 2023-05-02; 29(3)
Jornal Title
Human Reproduction Update
ISSN
1460-2369

Files:

NameSizeformatDescriptionLink